EPISODE · Apr 14, 2026 · 33 MIN
From Physician to Biotech CEO: Building High-Impact Clinical Development with Dr. Allison Jeynes
from Clinical Trialblazers · host Parexel
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Allison Jeynes, CEO of Nefro Avillion Clinical Development, to explore her remarkable journey from clinician to biotech leader. With over 30 years of experience and a track record that includes the development and approval of nearly 20 drugs, Allison shares how she built a 100% success-rate model in clinical development, and what it takes to sustain excellence in a high-risk industry. We hope you enjoyed this week’s episode of Clinical Trialblazers. Please take a moment to rate and review this podcast wherever you listen. Special thanks to our production partner, Wonder Media Network. Our producer is Brittany Martinez, our editor is Gianna Palmer and our production assistant is Joia Putnoi.
Embed this episode
What this episode covers
In this episode of Clinical Trialblazers, host Alberto Grignolo sits down with Dr. Allison Jeynes, CEO of Nefro Avillion Clinical Development, to explore her remarkable journey from clinician to biotech leader. With over 30 years of experience and a track record that includes the development and approval of nearly 20 drugs, Allison shares how she built a 100% success-rate model in clinical development, and what it takes to sustain excellence in a high-risk industry.
Ready to play
From Physician to Biotech CEO: Building High-Impact Clinical Development with Dr. Allison Jeynes
No transcript for this episode yet
Similar Episodes
No similar episodes found.